Bendamustine Hydrochloride
Overview
Bendamustine Hydrochloride is a bifunctional alkylating agent used for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin's lymphoma (NHL). It interferes with the growth of cancer cells by causing DNA cross-linking, leading to cell death.
API suppliers (8)
Suppliers of Bendamustine Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 6 of 8 suppliers.
4 of 8 hold a GMP certificate on record in the EU or UK registers
- Intas Pharmaceuticals Ltd.India1 active DMF GMP on record
- Natco Pharma Usa1 active DMF
- LABORCHEMIE APOLDA GMBHGermany1 active DMF GMP on record
- Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
- CHEMPACIFIC CORPUnited States1 active DMF
- FUXIN LONG RUI PHARMACEUTICAL CO LTD1 active DMF
- FRESENIUS KABI ONCOLOGY LTDIndia GMP on record
- ITF CHEMICAL LTDABrazil
Therapeutic areas
Do you supply Bendamustine Hydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.